# EDGAR Filing Document

**Accession Number:** 0001030894
**File Stem:** 0001193125-25-212764
**Filing Date:** 2025-7
**Character Count:** 6941
**Document Hash:** a6461a6ffbdd9165338f7dc9bdb011ba
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-212764.hdr.sgml**: 20251209

**ACCESSION NUMBER**: 0001193125-25-212764

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250701

**DATE AS OF CHANGE**: 20251209

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Wilson Michael Max
- **CENTRAL INDEX KEY:** 0002082884

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14832
- **FILM NUMBER:** 251332438

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 5140 YONGE STREET
- **STREET 2:** SUITE 1900
- **CITY:** TORONTO
- **PROVINCE COUNTRY:** A6
- **ZIP:** M2N 6L7
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CELESTICA INC
- **CENTRAL INDEX KEY:** 0001030894
- **STANDARD INDUSTRIAL CLASSIFICATION:** PRINTED CIRCUIT BOARDS [3672]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 980185558
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 5140 YONGE STREET, SUITE 1900
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M2N 6L7
- **BUSINESS PHONE:** 416-448-5800

**MAIL ADDRESS:**
- **STREET 1:** 5140 YONGE STREET, SUITE 1900
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M2N 6L7

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Wilson Michael Max<br><sub>(Last) (First) (Middle)</sub><br>5140 YONGE STREET<br>SUITE 1900<br><sub>(Street)</sub><br>TORONTO, A6 M2N 6L7<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-30 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>CELESTICA INC [ CLS ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Shares | 2025-06-30 |  | M |  | 5890 | A | $0 | 13391 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Share Units | <sup>(1)</sup> | 2025-06-30 |  | M |  |  | 3149 | <sup>(2)</sup> | <sup>(2)</sup> | Common Shares | 3149 | $0 | 0 | D |  |
| Restricted Share Units | <sup>(1)</sup> | 2025-06-30 |  | M |  |  | 2145 | <sup>(3)</sup> | <sup>(3)</sup> | Common Shares | 2145 | $0 | 2146 | D |  |
| Restricted Share Units | <sup>(1)</sup> | 2025-06-30 |  | M |  |  | 596 | <sup>(4)</sup> | <sup>(4)</sup> | Common Shares | 596 | $0 | 1191 | D |  |
| Director Share Units | <sup>(5)</sup> | 2025-06-30 |  | A |  | 671 |  | <sup>(5)</sup> | <sup>(5)</sup> | Common Shares | 671 | $0 | 671 | D |  |

---

### Footnotes:

(1) Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election.

(2) On June 30, 2022, the reporting person was granted 9,448 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

(3) On June 30, 2023, the reporting person was granted 6,437 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

(4) On June 30, 2024, the reporting person was granted 1,787 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

(5) Each director share unit represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to serve the Issuer as any of a director, consultant or other service provider.

**Signature:** /s/ Tracy Connelly McGilley, attorney-in-fact  
**Date:** 2025-07-01

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**